Giraffe Bio raises $6.4 million for copper recovery technology
The startup’s $6.4 million seed round will fund reagents designed to help existing mines recover more copper without rebuilding their flotation plants.
Giraffe Bio has raised $6.4 million in seed funding to develop biomolecular reagents that could help mines recover more copper from existing operations. TechCrunch reports that the round was led by Orion Industrial Ventures, with participation from BHP Ventures, Twynam, Air Capital and Baruch Future Ventures. 1
The startup is targeting a growing problem: demand from AI data centres, electrification and other industries could leave the world’s copper supply 25% short of demand by 2040, according to a study cited by TechCrunch. 1
How Giraffe Bio’s technology works
Rather than putting living microbes into a mine, Giraffe Bio uses engineered microbes in a bioreactor to produce bespoke compounds. Those compounds are then added to the existing flotation process, where chemicals help separate valuable minerals from waste. 1
The company says its mineral-specific reagents can improve copper recovery by up to 5%, although its own website notes that results vary with mineralogy and operating conditions. Its validation figures are based on lab-scale tests using real mine samples, not a universal guarantee for every operation. 2
Giraffe Bio says the reagents can be introduced through existing flotation circuits and dosing infrastructure, avoiding the need for new equipment or a redesigned flowsheet. The company also says it is developing depressors that could replace some more harmful chemicals used to bind unwanted minerals such as arsenic. 12
Why this matters for copper supply
Opening new mines is expensive and uncertain, so extracting more from existing ore could become increasingly valuable as demand rises. Giraffe Bio is not the only startup pursuing biotechnology in mining: TechCrunch also points to Endolith, Ceibo and Transition Metal Solutions, which are exploring microbial or prebiotic approaches to copper recovery. 1
The approach still needs to prove itself beyond laboratory validation and across different mineral deposits. Its appeal is that the proposed reagent is a drop-in addition to infrastructure mines already use, rather than a wholesale replacement for the flotation process.
Our opinion
Giraffe Bio’s pitch is strongest where it is most specific: better selectivity in an existing process is easier to imagine deploying than a fantasy of reinventing mining from scratch. The 3–5 percentage-point recovery figure needs to stay attached to its testing conditions, but even a smaller improvement could matter if it works consistently at commercial scale. This is promising industrial biotechnology, not a magic fix for copper scarcity.